Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly (BATS: QBF)

Últimas noticias sobre Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly (BATS:QBF)

Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

New ETFs

ETFs

$BTC

Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

Innovator Capital Management lanzó el Uncapped Bitcoin 20 Floor ETF – Quarterly (BATS:QBF), el 6 de febrero, con un ratio de gastos competitivo del 0,79 %.

Nuevo ETF de Bitcoin con protección contra pérdidas: Innovator lanza QBF

<p>Cantor Fitzgerald  analyst Josh Schimmer   reiterates Septerna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) with a Overweight and maintains $50 price target.</p>


News

Price Target

Reiteration

Analyst Ratings

SEPN

Cantor Fitzgerald Reiterates Overweight on Septerna, Maintains $50 Price Target

WIIM

ACGL

Arch Capital Group shares are trading lower. The company reported Q4 financial results.

<p><strong>Ecolab Inc&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) shares are trading higher after the company reported&nbsp;fourth-quarter sales growth of&nbsp;2% year-on-year to&nbsp;$4.005 billion,&nbsp;beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43620814/ecolab-delivers-strong-fourth-quarter-and-record-2024-performance-reported-diluted-eps-1-66-adjust" rel="noreferrer noopener">consensus estimate of&nbsp;$3.99 billion</a>.</p>
<p>Organic sales grew&nbsp;4%, led by strong<strong> </strong>growth in the Industrial and Healthcare &amp; Life Sciences segments and the Pest Elimination and Institutional &amp; Specialty segments.</p>
<p>In fixed currency, Global Industrial sales grew&nbsp;4% to&nbsp;$2.067<strong> </strong>billion, Global Institutional &amp; Specialty climbed&nbsp;6% to&nbsp;$1.367 billion, Global Healthcare &amp; Life Sciences fell&nbsp;23% to&nbsp;$322.1 million and Global Pest Elimination increased&nbsp;8% to&nbsp;$295.2 million.</p>
<p>Selling, general and administrative expenses rose 1% to $1.1 billion. Adjusted operating income for the quarter increased 10% to $688.2 million, with an adjusted operating margin of 17.3% vs. 15.9% a year ago.</p>
<p>Adjusted EPS of&nbsp;$1.81 (+17% Y/Y) <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus estimate of&nbsp;$1.79</a>.</p>
<p>The company held&nbsp;$1.26 billion in cash and equivalents as of December end.</p>
<p><strong>Outlook</strong>: Ecolab expects first-quarter adjusted EPS of $1.47 &#8211; $1.53, vs. the $1.48 estimate, and 2025 adjusted EPS of $7.42 &#8211; $7.62, <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">compared to the $7.40 estimate</a>.</p>
<p>Christophe Beck, Ecolab&#8217;s chairman and chief executive officer, said,</p>
<p>&#8220;We enter 2025 confident in our ability to deliver continued strong performance in a dynamic environment. Growth in the United States, our largest and most profitable region, continues to be very strong, and growth across the rest of the world is solid as we more than offset uneven macroeconomic trends.&#8221;</p>
<p>&#8220;Additionally, we will implement value pricing that reflects the increasing value Ecolab delivers to customers. As a result, we expect to deliver attractive organic operating income margin expansion, as our confidence in reaching our 20% margin target over the next three years continues to strengthen.&#8221;</p>
<p>Investors can gain exposure to the stock via&nbsp;<strong>VanEck Environmental Services ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVX#NYSE">EVX</a>) and&nbsp;<strong>Invesco Water Resources ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHO#NASDAQ">PHO</a>)</p>
<p><strong>Price Action</strong>: ECL shares are up 6.76% at $262.57 at the last check Tuesday.</p>
<p><strong>Read Next</strong>:</p>
<ul>
<li><strong><a href="https://www.benzinga.com//node/43622400" target="_blank" rel="noreferrer noopener">Sam Altman Says Elon Musk&#8217;s $97B Bid For OpenAI Is A Move To &#8216;Slow Down A Competitor&#8217;</a></strong></li>
</ul>


Earnings

Equities

Large Cap

Guidance

Movers

Market Vectors Environmental Services Index Fund

PowerShares Exchange Traded Fund Water Resource Portfolio

Ecolab Q4: Solid EPS Growth, Industrial And Institutional Acceleration, 2025 Momentum And More

<p><strong>Vertex Pharmaceuticals Incorporated</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) reported mixed results for its fourth <a href="https://www.benzinga.com/quote/VRTX/earnings">quarter on Monday</a>.</p>
<p>The company posted quarterly adjusted earnings of $3.48 per share which missed the analyst consensus estimate of $4.03 per share. The company reported quarterly sales of $2.912 billion which beat the analyst consensus estimate of $2.781 billion.</p>
<p>&#8220;2024 marked a year of tremendous growth for Vertex and we anticipate 2025 will be another important year with the landmark JOURNAVX approval and launch for moderate-to-severe acute pain; the launch of our fifth CF medicine, ALYFTREK; the continuing global launch of CASGEVY; and multiple ongoing pivotal trials. We are excited to drive diversification of the revenue base, disease areas of focus, R&amp;D pipeline, and geographies to continue to deliver long-term value to both patients and shareholders,&#8221; said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex.</p>
<p>Vertex Pharmaceuticals said it sees FY25 revenue of $11.75 billion to $12.00 billion, versus market estimates of $11.84 billion.</p>
<p>Vertex Pharmaceuticals shares fell 2.5% to trade at $458.15 on Tuesday.</p>
<p>These analysts made changes to their price targets on Vertex Pharmaceuticals following earnings announcement.</p>
<ul>
<li>Morgan Stanley analyst Matthew Harrison maintained Vertex Pharmaceuticals with an Equal-Weight and raised the price target from $450 to $459.</li>
<li>Barclays analyst Gena Wang maintained the stock with an Equal-Weight and raised the price target from $435 to $46.</li>
<li>HC Wainwright &amp; Co. analyst Andrew Fein, meanwhile, reiterated Vertex Pharmaceuticals with a Buy and maintained a $550 price target.</li>
</ul>
<p><strong>Considering buying VRTX stock? Here&#8217;s what analysts think:</strong> </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="625" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-1024x625.png" alt="" class="wp-image-776741" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-1024x625.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97-768x468.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11095438/image-97.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/02/43592071/top-3-tech-stocks-that-may-jump-this-month">Top 3 Tech Stocks That May Jump This Month</a></strong></li>
</ul>


Markets

Trading Ideas

VRTX

Vertex Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results

<p>Scotiabank  analyst Greg Harrison   maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Sector Perform and raises the price target from $433 to $450.</p>


Scotiabank Maintains Sector Perform on Vertex Pharmaceuticals, Raises Price Target to $450

<p>Cantor Fitzgerald  analyst Olivia Brayer   reiterates Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Overweight and maintains $480 price target.</p>


Cantor Fitzgerald Reiterates Overweight on Vertex Pharmaceuticals, Maintains $480 Price Target

<p>Scotiabank  analyst  Allan Verkhovski   maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Sector Outperform and raises the price target from $300 to $400.</p>


MNDY

Scotiabank Maintains Sector Outperform on Monday.Com, Raises Price Target to $400

<p><a href="https://event.webcasts.com/starthere.jsp?ei=1705636&amp;tp_key=ba14762bab&amp;tp_special=8" title="https://event.webcasts.com/starthere.jsp?ei=1705636&amp;tp_key=ba14762bab&amp;tp_special=8">https://event.webcasts.com/starthere.jsp?ei=1705636&amp;tp_key=ba14762bab&amp;tp_special=8</a></p>


JPMorgan CFO Says Board Is Thinking About Succession Planning With Fairness And Focus As Ever

<p>Scotiabank  analyst George Farmer   maintains INmune Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) with a Sector Outperform and raises the price target from $22 to $23.</p>


INMB

Scotiabank Maintains Sector Outperform on INmune Bio, Raises Price Target to $23

CARR

Carrier Global shares are trading lower after the company reported worse-than-expected Q4 sales results.

<p><strong>Edgewell Personal Care Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) reported downbeat financial results for the <a href="https://www.benzinga.com/quote/EPC/earnings">first quarter on Monday</a>.</p>
<p>Edgewell Personal Care reported quarterly adjusted earnings of 7 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $478.40 million which missed the analyst consensus estimate of $480.07 million.</p>
<p>Edgewell Personal Care said it sees FY25 adjusted EPS of $3.15 to $3.35, versus estimates of $3.18.</p>
<p>Edgewell Personal Care shares gained 2.5% to trade at $29.33 on Tuesday.</p>
<p>These analysts made changes to their price targets on Edgewell Personal Care following earnings announcement.</p>
<ul>
<li>Morgan Stanley analyst Dara Mohsenian maintained Edgewell Personal Care with an Underweight and lowered the price target from $35 to $32.</li>
<li>Wells Fargo analyst Chris Carey maintained the stock with an Overweight and lowered the price target from $37 to $35.</li>
<li>RBC Capital analyst Nik Modi maintained Edgewell Personal Care with an Outperform and lowered the price target from $48 to $43.</li>
<li>Barclays analyst Lauren Lieberman maintained the stock with an Equal-Weight and lowered the price target from $33 to $30.</li>
</ul>
<p><strong>Considering buying EPC stock? Here&#8217;s what analysts think:</strong> </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="619" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-1024x619.png" alt="" class="wp-image-776722" style="width:707px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-1024x619.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-300x181.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96-768x464.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11094659/image-96.png 1096w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/02/43592071/top-3-tech-stocks-that-may-jump-this-month">Top 3 Tech Stocks That May Jump This Month</a></strong></li>
</ul>


Edgewell Personal Care Analysts Cut Their Forecasts After Weak Earnings

<p>Cantor Fitzgerald  analyst Yi Fu Lee   initiates coverage on Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) with a Overweight rating and announces Price Target of $11.</p>


Initiation

DOMO

Cantor Fitzgerald Initiates Coverage On Domo with Overweight Rating, Announces Price Target of $11

Dividends

PSEG Increases Quarterly Dividend From $0.60 To $0.63

<p>Financial giants have made a conspicuous bullish move on PayPal Holdings. Our analysis of options history for PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $131,116, and 5 were calls, valued at $227,058.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $65.0 to $97.5 for PayPal Holdings over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for PayPal Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across PayPal Holdings's significant trades, within a strike price range of $65.0 to $97.5, over the past month.</p>
<h3>PayPal Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739285151_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$9.1</td>
<td>$9.0</td>
<td>$9.0</td>
<td>$70.00</td>
<td>$63.0K</td>
<td>384</td>
<td align="right">3</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$23.7</td>
<td>$22.3</td>
<td>$22.31</td>
<td>$97.50</td>
<td>$51.2K</td>
<td>188</td>
<td align="right">24</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.15</td>
<td>$3.0</td>
<td>$3.15</td>
<td>$77.50</td>
<td>$48.1K</td>
<td>1.8K</td>
<td align="right">2</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$15.65</td>
<td>$15.2</td>
<td>$15.65</td>
<td>$65.00</td>
<td>$46.9K</td>
<td>33</td>
<td align="right">30</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$77.50</td>
<td>$45.5K</td>
<td>5.4K</td>
<td align="right">147</td>
</tr>
</tbody>
</table>
</p>
<h3>About PayPal Holdings</h3>
<p>PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 426 million active accounts at the end of 2023. The company also owns Venmo, a person-to-person payment platform.</p>
<p>After a thorough review of the options trading surrounding PayPal Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is PayPal Holdings Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 718,045, the PYPL's price is down by -1.56%, now at $77.02. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PayPal Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

PYPL

PayPal Holdings Unusual Options Activity For February 11

<p>Deep-pocketed investors have adopted a bullish approach towards Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Advanced Micro Devices. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 60% leaning bullish and 20% bearish. Among these notable options, 5 are puts, totaling $223,942, and 5 are calls, amounting to $158,797.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $95.0 to $200.0 for Advanced Micro Devices over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Advanced Micro Devices's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Advanced Micro Devices's whale trades within a strike price range from $95.0 to $200.0 in the last 30 days. </p>
<h3>Advanced Micro Devices Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739285146_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$76.8</td>
<td>$73.0</td>
<td>$73.45</td>
<td>$180.00</td>
<td>$88.1K</td>
<td>304</td>
<td align="right">12</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$5.75</td>
<td>$5.65</td>
<td>$5.65</td>
<td>$95.00</td>
<td>$44.0K</td>
<td>3.7K</td>
<td align="right">73</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$31.35</td>
<td>$31.2</td>
<td>$31.35</td>
<td>$110.00</td>
<td>$37.6K</td>
<td>2.3K</td>
<td align="right">3</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$1.75</td>
<td>$1.73</td>
<td>$1.75</td>
<td>$110.00</td>
<td>$35.0K</td>
<td>6.7K</td>
<td align="right">968</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$6.85</td>
<td>$6.8</td>
<td>$6.8</td>
<td>$105.00</td>
<td>$33.9K</td>
<td>4.4K</td>
<td align="right">50</td>
</tr>
</tbody>
</table>
</p>
<h3>About Advanced Micro Devices</h3>
<p>Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.</p>
<h3>Current Position of Advanced Micro Devices</h3>
<ul>
<li>With a trading volume of 929,896, the price of AMD is down by -0.73%, reaching $109.67.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 77 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Advanced Micro Devices</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $167.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Rosenblatt has decided to maintain their Buy rating on Advanced Micro Devices, which currently sits at a price target of $250.<br />
&#x2A; An analyst from Benchmark persists with their Buy rating on Advanced Micro Devices, maintaining a target price of $170.<br />
&#x2A; An analyst from B of A Securities persists with their Neutral rating on Advanced Micro Devices, maintaining a target price of $135.<br />
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Advanced Micro Devices with a target price of $140.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Advanced Micro Devices, targeting a price of $140. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Advanced Micro Devices options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Smart Money Is Betting Big In AMD Options

<p>Deep-pocketed investors have adopted a bearish approach towards Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in META usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Meta Platforms. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 36% leaning bullish and 54% bearish. Among these notable options, 6 are puts, totaling $605,443, and 5 are calls, amounting to $981,482.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $600.0 to $730.0 for Meta Platforms during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Meta Platforms's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Meta Platforms's whale activity within a strike price range from $600.0 to $730.0 in the last 30 days. </p>
<h3>Meta Platforms Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739285141_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>META</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$78.9</td>
<td>$77.05</td>
<td>$78.2</td>
<td>$637.50</td>
<td>$781.4K</td>
<td>222</td>
<td>100</td>
</tr>
<tr>
<td>META</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$39.2</td>
<td>$38.85</td>
<td>$38.85</td>
<td>$725.00</td>
<td>$194.2K</td>
<td>495</td>
<td>99</td>
</tr>
<tr>
<td>META</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$7.4</td>
<td>$7.2</td>
<td>$7.4</td>
<td>$710.00</td>
<td>$162.7K</td>
<td>3.4K</td>
<td>1.7K</td>
</tr>
<tr>
<td>META</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$4.2</td>
<td>$4.05</td>
<td>$4.1</td>
<td>$700.00</td>
<td>$102.5K</td>
<td>6.9K</td>
<td>1.9K</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$45.25</td>
<td>$44.9</td>
<td>$45.0</td>
<td>$730.00</td>
<td>$90.0K</td>
<td>524</td>
<td>28</td>
</tr>
</tbody>
</table>
</p>
<h3>About Meta Platforms</h3>
<p>Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.</p>
<p>Having examined the options trading patterns of Meta Platforms, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Meta Platforms</h3>
<ul>
<li>Currently trading with a volume of 269,975, the META's price is down by -0.73%, now at $712.19. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 71 days.</li>
</ul>
<h3>What Analysts Are Saying About Meta Platforms</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $752.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Market Perform rating on Meta Platforms with a target price of $610.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Meta Platforms, maintaining a target price of $786.<br />
&#x2A; An analyst from Truist Securities persists with their Buy rating on Meta Platforms, maintaining a target price of $770.<br />
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Meta Platforms, maintaining a target price of $846.<br />
&#x2A; An analyst from Baird persists with their Outperform rating on Meta Platforms, maintaining a target price of $750. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Meta Platforms options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Unpacking the Latest Options Trading Trends in Meta Platforms

<p>Trane Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) has outperformed the market over the past 20 years by 4.57% on an annualized basis producing an average annual return of 12.98%. Currently, Trane Technologies has a market capitalization of $80.98 billion. </p>
<p><strong>Buying $100 In TT:</strong> If an investor had bought $100 of TT stock 20 years ago, it would be worth <strong>$1,145.06</strong> today based on a price of $359.87 for TT at the time of writing.</p>
<h3>Trane Technologies's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739285122_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

Watching Tempus, Company To Report Q4 And FY24 Financial Results On Feb. 24

<p>Barclays  analyst Gena Wang   maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Equal-Weight and raises the price target from $435 to $467.</p>


Comments

Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

Noticias

Últimas noticias sobre Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly (BATS:QBF)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL